Park [90] found that 19-nor-1,25-dihydroxyvitamin D2, a vitamin D analog, could block cell cycle of MKN45 gastric cancer cells by decreasing the expression of cyclin-dependent kinase(CDK), CDK2, CDK4, CDK6 and Cyclin D1. This evidence concerns the gene CDK6 and gastric cancer.